11-64226759-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032344.4(NUDT22):c.107G>A(p.Gly36Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,610,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G36C) has been classified as Likely benign.
Frequency
Consequence
NM_032344.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUDT22 | NM_032344.4 | c.107G>A | p.Gly36Asp | missense_variant | 2/6 | ENST00000279206.8 | NP_115720.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUDT22 | ENST00000279206.8 | c.107G>A | p.Gly36Asp | missense_variant | 2/6 | 1 | NM_032344.4 | ENSP00000279206.3 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152210Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000177 AC: 44AN: 248134Hom.: 0 AF XY: 0.000171 AC XY: 23AN XY: 134692
GnomAD4 exome AF: 0.000110 AC: 160AN: 1458210Hom.: 0 Cov.: 32 AF XY: 0.000114 AC XY: 83AN XY: 725584
GnomAD4 genome AF: 0.000131 AC: 20AN: 152328Hom.: 0 Cov.: 34 AF XY: 0.000148 AC XY: 11AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 31, 2022 | The c.107G>A (p.G36D) alteration is located in exon 2 (coding exon 1) of the NUDT22 gene. This alteration results from a G to A substitution at nucleotide position 107, causing the glycine (G) at amino acid position 36 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at